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Abstract 
Synovial white blood cell (WBC) count and the percentage of polymorphonuclear leucocytes 
(PMN%) is one of the diagnostic criteria to diagnose a periprosthetic joint infection (PJI). Although 
the test is widely available, the diagnostic accuracy of proposed cut-off levels are influenced by 
several factors, such as: the affected joint, co-morbid conditions, the causative microorganism and 
the gathering and processing of samples in the laboratory. In this narrative review we provide an 
overview on how and to what extent these factors can affect the synovial WBC count and PMN% in 
synovial fluid. 
Key words: periprosthetic joint infection, synovial fluid, diagnosis, white blood cell count, polymorphonuclear 
percentage 
Introduction 
The diagnosis of a periprosthetic joint infection 
(PJI) is challenging especially for chronic PJIs. Because 
there is no single and absolute test to confirm or 
exclude infection [1-7], patients’ history, physical 
examination, joint specific x-ray or other types of 
imaging, histology, culture and inflammatory 
markers should all be taken into consideration for 
diagnosis. It is critical to distinguish between septic 
and aseptic failure preoperatively, as arthroplasty 
exchange of a missed PJI leads to subsequent failure 
[8,9]. Criteria for the diagnosis of PJI have been 
proposed by the Musculoskeletal Infection Society 
(MSIS) and the International Consensus Meeting 
(ICM) [10-12]. One of them includes the synovial 
white blood cell (WBC > 3000cells/µL) count and its 
proportion of polymorphonuclear cells (PMN% > 70). 
The test can be performed relatively easily in the 
preoperative diagnostic work-up. Its sensitivity, 
specificity and diagnostic accuracy depends on the 
threshold that is applied. Factors such as joint site, 
co-morbid conditions, the causative microorganism 
and the duration of infection, in addition to 
pre-analytical laboratory variables, may influence the 
optimal cut-off result [13]. This narrative review 
provides an overview of these factors and its possible 
influence on the threshold and accuracy of the WBC 
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count and PMN% in synovial fluid for PJIs. 
Search strategy and selection criteria 
We identified references for this narrative review 
through searches of PubMed and Embase electronic 
databases by using the following combinations of 
terms (alternative terms grouped in parentheses): 
(“synovial*” OR “joint fluid” OR “synovial fluid”) 
AND (“white blood cell” OR “WBC” OR “leucocyte” 
OR “polymorphonuclear” OR “PMN”) AND 
(“count*” OR “differentiation” OR “analysis”)). We 
included publications from January 1966 to December 
2018. The title and abstract were screened to identify 
the references applicable to the different research 
questions of this review, after which the full text 
articles were evaluated. 
Historical perspective: from native to 
prosthetic joints 
Synovial fluid analysis has traditionally been 
considered in native joints to differentiate between 
non-inflammatory (typically with a WBC count of < 
2,000 cells/µL and PMN% of < 25) and inflammatory 
arthritis[14,15]. In a systematic review on native septic 
arthritis, synovial WBC count of >25,000 cells/µL, 
>50,000 cells/µL and >100,000 cells/µL revealed a 
sensitivity of 77%, 62% and 29% and a specificity of 
73%, 92% and 99%, respectively[16].  
The diagnostic use of joint aspiration before 
revision arthroplasty was first described by Duff et al. 
[17] in 1996. The authors retrospectively reviewed the 
preoperative aspiration results of 43 knees between 
1985 and 1995. They investigated microbiological 
growth but did not report results of WBC count 
analyses. Spangehl et al. [18] prospectively analysed 
the WBC count in synovial fluid in 183 cases during 
revision of total hip arthroplasties (THAs) from 1994 
to 1996. The authors considered it a positive finding if 
the WBC count was > 50,000 cells/µL or the PMN% 
was > 80% (i.e.; cut-offs used for native septic 
arthritis). They reported a good specificity of 99% 
(96%–100%) but a poor sensitivity of 36% (19%–56%). 
Kersey et al. [19] reported a mean WBC count of 782 
cells/µL (11 to 7,200/µL) and a PMN% of 13 in 77 
total knee arthroplasties (TKAs) undergoing revision 
for ‘aseptic failure’ from 1992 to 1997. The authors 
calculated that a WBC count of <2,000/µL and a 
PMN% of < 50 had a 98.3% negative predictive value 
for excluding infection.  
In 2003, Mason et al. [20] demonstrated an 
important finding for the diagnosis of PJI. The 
specificity for diagnosing PJI with a WBC count 
cut-off value of 50,000 cells/µL is similar to the 
specificity of using a value of 2,500 cells/µL. They 
retrospectively reviewed preoperative aspiration data 
of 86 knees from 1986 to 1997 and calculated a 
specificity of 95% and sensitivity of 98% for 
diagnosing PJI when using a WBC count cut-off value 
of 2,500 cells/µL combined with a PMN% of > 60. 
After Trampuz et al. [21] (1,700 cells/µL for knee PJI) 
and Schinsky et al. [22] (3,000 to 4,200 cells/µL for hip 
PJI) reported similar findings in 2004 and 2008, 
respectively, it was apparent that considerably lower 
WBC count cut-off values should be used for the 
diagnosis of PJI than for the diagnosis of native septic 
arthritis.  
The confusion about the units 
The observation that lower cut-off levels for the 
synovial WBC count were necessary in prosthetic 
joints than in native joints (i.e., more than 1 log), 
together with the use of different units, can cause 
some confusion in the nomenclature. The frequently 
quoted unit is cells/µL [23], equivalent to cells/mm3, 
106 cells/ L or cells/10-3cm3. The units may vary 
between institutions, depending on laboratory 
practice. Thus, attention to detail is required when 
converting the results from one unit to another to 
prevent errors [24]. 
Factors potentially influencing synovial 
WBC count thresholds  
Synovial WBC count cut-off values ranging from 
1,000 to 5,000 cells/μL for the diagnosis of chronic hip 
and knee PJI have been published. Subsequently, 
there is an ongoing discussion about the optimal 
cut-off value. For simplicity, surgeons and physicians 
like to use a single optimal cut-off value. However, 
several variables may influence the final result, as 
discussed in the following paragraphs.  
Preanalytical steps 
• USE OF LOCAL ANAESTHETICS: The 
influence of local anaesthetics on synovial fluid 
WBC has not been studied. However, local 
anaesthetics and related compounds may inhibit 
the growth of bacteria, presumably because of 
the acidity of most anaesthetic compounds. 
Therefore, local anaesthetics prior to joint 
puncture is discouraged [25]. 
• PRIOR USE OF ANTIBIOTICS: Lower WBC 
counts and PMN% in synovial fluid have been 
found in patients treated with antimicrobial 
therapy than in patients without antibiotic 
therapy [26]. Therefore, antibiotics should be 
withheld in suspected chronic PJIs until a proper 
diagnostic work-up has been performed.  
• VOLUME: The optimal synovial fluid volume 
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for analyses of WBC count is typically 1 mL or 
more. However, depending on the analytical 
procedure, smaller volumes are possible (e.g., 
250 µL). It is important to interact closely with 
laboratory experts to clarify these details, since 
there are inter-institutional differences in 
standard operating procedures between 
laboratories. 
• DRY TAP: In case of a punctio sicca (“dry tap”), 
injection and re-aspiration of sodium chloride 
may be helpful to obtain bacterial culture. 
However, WBC analysis is not reliable anymore 
and should not be performed. Of note, dry tap 
does not exclude an infection, and the frequency 
of dry taps may vary between joints. In a study 
by Zahar et al. [27], a complete synovial fluid 
analysis was available in only 64% of all studied 
patients with a hip or knee arthroplasty joint due 
to a limited amount of synovial fluid, a clotted 
specimen or a bloody aspirate. 
• CLOTTING: To prevent clotting, synovial fluid 
should be collected in ethylenediaminetetraace-
tate (EDTA) tubes. The tube should be turned 
upside down several times to mix the EDTA 
with the synovial fluid. Mucous samples are - 
due to its increased viscosity - difficult to pipet. 
The viscosity may also form a problem for 
automated cell analysers in aspirating a 
sufficient amount of fluid. Pre-treatment of the 
sample with hyaluronidase reduces the viscosity 
of synovial fluid and improves the accuracy of 
cytometric analysis, irrespective of whether 
optical or automated techniques are used [28]. Of 
note, an EDTA tube is not preferred for crystal 
examination. 
• BLOODY ASPIRATE: In the case of an aspirate 
with a high number of red blood cells (RBCs), it 
is possible to calculate an approximation of 
corrected values for the synovial WBC count by 
using a mathematical model and the serum WBC 
count [29]. The adjusted synovial WBC count can 
be calculated with the following formula: 
synovial WBC adjusted = synovial WBC observed – 
[(WBC blood / RBC blood) × RBC synovial fluid] [30]. 
Discussion of the results with a laboratory expert 
is advised in these cases. 
• TRANSPORT: Ex vivo cell lysis may occur 
during prolonged transport. Rapid transport of 
the sample to the laboratory with swift analysis 
of the material may prevent cell lysis. The 
optimal time interval has not been investigated 
for patients with PJI. We recommend analysis 
within 1 hour, preferentially within 30 minutes, 
of aspiration. 
• LABORATORY CELL COUNTING: Studies 
have demonstrated that standardized automated 
counting of WBCs in synovial fluid is more 
accurate and efficient than manual counting 
[31-33]. Manual counting of WBCs in synovial 
fluid results in an inter-observer variance of > 20% 
[28,31,34]. In case of frank pus or metal on metal 
arthroplasty, the sample consists of high 
numbers of necrotic and apoptotic leucocytes. 
These cellular debris may result in false results in 
automated systems. In such a scenario, samples 
should be manually counted by a laboratory 
technician. 
Joint site 
The location of the affected joint has an effect on 
the optimal threshold of the WBC count and the 
PMN%. A possible hypothesis for this is because of 
the differences in joint space/volume, synovial lining 
and vascularization. All of these factors theoretically 
may be influence the concentration of WBC and 
PMN% in a joint. 
• HIP: Several studies investigated WBC count 
and PMN% in PJI diagnosis of the hip [27,35-45]. 
These studies indicate an optimal cut-off for the 
WBC count of 3,000 cells/μL and a PMN% of 65. 
This cut-off value was supported by a recent 
meta-analysis that demonstrated subsequent 
sensitivity and specificity of 90% (95% 
confidence interval [CI] 0.828–0.938) and 86% (95% 
CI 0.704–0.939), respectively, for the WBC count 
and of 88% (95% CI 0.818–0.927) and 82% (95% 
CI 0.759–0.870), respectively, for PMN%. 
• KNEE: We reviewed 15 studies that investigated 
the WBC count and PMN% in PJI diagnosis of 
the knee [27,35,37,38,42,46-55]. In a meta-analysis 
performed by De Fine et al., a higher diagnostic 
accuracy was observed in TKA PJI compared to 
THA PJI (Table 1) when using a threshold of 
3,000 cells/µL and a PMN% of >65 [55]. It should 
be noted that due to the lack of an adequate 
number of clinical studies specifically involving 
TKAs, the precise assessment of the optimal 
cut-off threshold for TKA PJI was precluded in 
the meta-analysis [55]. Zahar et al. [27] 
performed a single-centre retrospective study 
that included 179 patients with TKA. The 
authors calculated an optimal cut-off threshold 
for the WBC count of 1,630 cells/μL with a 
sensitivity of 84% and specificity of 82%. The 
optimal cut-off for PMN% was set at 61, 
resulting in a sensitivity of 80% and a specificity 
of 77% [27]. Together with the previously 
mentioned data of Mason et al. [20] and Trampuz 
et al. [21], the results tended to demonstrate 
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lower cut-off levels in knee joints than in hip 
joints. 
• SHOULDER: Only a few studies have evaluated 
the diagnostic accuracy of the WBC count and 
PMN% in shoulder arthroplasties, and all of 
these studies comprised small cohorts [56,57]. 
Recently, Strahm et al. [58] analysed 19 failed 
shoulder implants in which a WBC count and 
PMN% was performed prior to revision surgery. 
Sixteen of these cases (84%) were diagnosed with 
infection; the optimal synovial WBC count 
threshold was 12,200 cells/μL (sensitivity 92% 
and specificity 100%) and the optimal PMN% 
threshold was 54 (sensitivity 100% and 
specificity 75%). This higher threshold for 
infection in shoulders compared with hips and 
knees was also observed in previous reports [59]. 
These data indicate that a different threshold 
should be applied for shoulder arthroplasties, 
but larger studies are needed to confirm these 
findings. 
• ANKLE AND ELBOW: The joint volume of the 
ankle and elbow is limited. This is particularly 
the case after previous surgery and the presence 
scar tissue. Consequently, synovial fluid can 
rarely be aspirated and no published data is 
available about the diagnostic accuracy of WBC 
count and PMN% in the ankle [60] or elbow [61]. 
 
 
Table 1. Synovial fluid analysis in THA vs TKA according to the 
meta-analysis of De Fine et al. [55]. 
WBC count 3,000 cells/µL Sensitivity 95% CI Specificity 95% CI 
THA 0.89 0.83–0.93 0.86 0.72–0.93 
TKA 0.90 0.77–0.96 0.94 0.63–0.99 
PMN% > 65 Sensitivity 95% CI  Specificity 95% CI 
THA 0.88 0.82–0.93 0.82 0.75–0.88 
TKA 0.93 0.80–0.98 0.90 0.76–0.97 
 
 
Co-morbid conditions  
It is conceivable that co-morbid conditions and 
immunosuppressive drugs have an influence on the 
production and function of leucocytes. 
• INFLAMMATORY ARTHRITIS: Because an 
inflammatory arthritis causes an increase in 
synovial WBC [62], it is reasonable to assume a 
different treshold in a rheumatic than in a 
non-rheumatic joint with PJI. However, the 
study by Cipriano et al. [37] indicated that there 
is no clear difference in thresholds for the WBC 
count and PMN% for diagnosing a PJI in patients 
with and without inflammatory arthritis. Indeed, 
the meta-analysis performed by Qu et al. [63], in 
which the authors compared 8 studies that 
excluded patients with inflammatory arthritis 
(n=2102) with 6 studies that included patients 
with inflammatory arthritis (n=598), 
demonstrates no differences in the diagnostic 
accuracy of synovial fluid WBC count and PMN% 
between groups. Because of the high 
heterogeneity of the included studies, the 
authors were not able to determine the optimal 
cut-off values in the meta-analysis [63]. In a 
multicentre study performed by Shohat et al. [64] 
that included 1,220 patients undergoing revision 
arthroplasty, thresholds for WBC count 
associated with PJI in patients with and without 
inflammatory arthritis were 2,533 and 2,683 
cells/μL, respectively, and 73 and 72 for PMN%. 
Notably, in this analysis, the sensitivity was 
approximately 8% higher and the specificity 
approximately 15% lower in patients with 
inflammatory arthritis than in patients without 
inflammatory arthritis. However, the same 
thresholds were applied for both patient 
categories. The use of immunosuppressive drugs 
were not taken into account in these studies. 
• METAL-ON-METAL (MoM) PROSTHESIS: In 
MoM prosthesis, metal wear from either the 
trunnion between the stem and the head or from 
the joint line of the THA, causes free metal 
particles. These particles may cause 
lymphocyte-dominated vasculitis-associated 
lesions (ALVAL) [40]. Both the free metal 
particles and the subsequent inflammatory 
reaction make the synovial fluid analysis more 
difficult to perform, and also, to interpret. The 
diagnosis of PJI in patients with failed MoM 
bearings and/or corrosion reactions in hip 
arthroplasties is challenging [65]. The clinical 
presentation can mimic a PJI, and aspiration of 
joint fluid may demonstrate pus [66]. Hence, 
analysis of synovial fluid sample is not possible 
in these cases, because of the presence of metal 
or amorphous material, fragmented cells and/or 
clots. A manual count may identify the presence 
of metal or amorphous material. Also, the 
synovial WBC and PMN% are false positive for 
infection in these cases [66]. However, the 
proportion of these misleading results in patients 
with MoM is difficult to assess [40,44]. Several 
studies demonstrated a relatively high 
diagnostic accuracy of synovial WBC count and 
PMN% for the diagnosis of PJI in patients with 
MoM. In a study including 102 MoM THAs, the 
optimal cut-off threshold for the WBC count in 
diagnosing PJI was 3,111 cells/μL (sensitivity 
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94%, specificity 86%), and thus, similar to 
non-MoM prostheses. The optimal cut-off for 
PMN% was 85 with a sensitivity of 82% and 
specificity of 87% [66].  
• CRYSTAL-INDUCED ARTHRITIS IN 
ARTHROPLASTY: Crystal-induced arthritis 
(gout, pseudogout) in a periprosthetic joint is a 
rare phenomenon [67-70]. Analysis for crystal 
disease should always be included in the 
diagnostic workup of PJI, in particular in the 
case of predisposing factors for (pseudo) gout, 
such as alcohol abuse, renal failure or the use of 
diuretics, especially in patients with an acute 
presentation of arthritis [71]. Crystal-induced 
arthritis may present with clinical manifestations 
that are identical to those of a PJI [72], and high 
WBC counts are reported in cases of acute gout 
(e.g.; up to 500,000 cells/µL) [73]. It should be 
noted that the presence of crystal arthritis does 
not rule out a concurrent PJI. Patients with 
crystal-induced diseases may have a incidence of 
PJIs than patients without gout or pseudogout 
[74,75].  
Causative microorganism and bacterial 
inoculum 
The microorganisms causing PJI largely depend 
on the type of infection (acute or chronic). Most 
diagnostic studies that evaluate the WBC count do not 
describe the cultured microorganisms. It is reasonable 
to assume that low-grade microorganisms, such as 
Cutibacterium acnes, cause a different or limited 
immunological response in comparison to that of 
more virulent microorganisms, like Staphylococcus 
aureus, Streptococcus species or Gram negatives [76,77]. 
Indeed, it has been demonstrated that the sensitivity 
of several (synovial) biomarkers in C. acnes PJIs are 
moderate to poor [77,78]. Recently, Kheir et al. [79] 
described the accuracy of several diagnostic tests per 
causative microorganism in 549 chronic PJIs and 653 
aseptic revisions. The optimal cut-off for the WBC 
count was around 2,700–3,000 cells/μL irrespective of 
the causative microorganism, but appeared to be 
lower for Enterococcus species (optimal cut-off of 
around 1,700 cells/μL). The same applied to the 
PMN%, which was ~65 for most microorganisms, but 
~58 for Enterococcus species. Notably, only 14 PJIs 
caused by enterococci were included in the study and 
infections caused by C. acnes were not reported in this 
cohort.  
Currently applied thresholds for WBC 
count in synovial fluid  
Different institutions have different practices 
regarding the use of one cut-off level for all joints or 
the use of joint-specific cut-off levels. In the latter case, 
providers frequently use WBC count cut-offs of 1,100 
to 1,700 cells/µL for knee PJI and 3,000 to 4,200 for hip 
PJI [27,53,55]. Renz et al. [80] suggested >2,000 
cells/µL and >70% PMN for both joint sites and 
demonstrated a sensitivity of 85.5% (95% CI 75.6–92.6) 
and a specificity of 92.3% (95% CI 86.3-96.3). In a 
meta-analysis, a cut-off threshold for WBC count of 
>3,000 cells/μL (irrespective of joint site) was 
calculated to have the highest sensitivity of 89% (95% 
CI 0.86–0.91) and specificity of 86% (95% CI 0.80–0.90) 
[55]. A cut-off threshold for PMN% of >65 was 
calculated to have the highest sensitivity of 89% (95% 
CI 0.82–0.93) and specificity of 86% (95% CI 0.77–0.92) 
[81]. A recent study by Zahar et al. [27] solely analysed 
patients with a chronically painful hip and knee 
arthroplasty; data on the WBC count was available in 
337 cases. The proposed cut-off in this study was in 
accordance with the previously proposed thresholds 
for infection of >3,000 cells/μL and a PMN% of 65. 
During the second International Consensus Meeting 
on Musculoskeletal Infections in Philadelphia, the 
agreed threshold for WBC count was >3,000 cells/μL 
and a PMN% of 70%, although a cut-off of 80% was 
validated in a cohort of 684 infected cases and 820 
aseptic revisions for the latter [82,83]. The 
discrepancies in proposed cut-offs between studies 
may be due to differences in the type of infections 
included (acute / chronic) and/or how the control 
groups without an infection are defined (e.g., 
exclusion or inclusion of coinflammatory conditions, 
metallosis). 
Conclusion 
The synovial WBC count result is only one of 
several diagnostic results that may lead to a definite 
diagnosis of PJI. A threshold of > 3,000 cells/μL and a 
PMN% of > 70 has been recently suggested [84]. Most 
studies, however, have suggested WBC count cut-off 
values ranging from 1,100 to 4,200 cells/μL and 60% 
to 89% for PMN% for the diagnosis of PJI which may 
be due to differences in included infections (acute and 
chronic) and the defined control group.  
In order to improve the diagnostic accuracy 
providers should pay attention to pre-analytic steps, 
the joint site, comorbidities and conditions that can 
mimic PJI.  
The vast majority of studies on the subject of this 
review stem from chronic hip and knee PJI. A lower 
WBC count cut-off than 3000 cells/μL may be applied 
for knees to diagnose a PJI. The synovial WBC count 
in inflammatory conditions such crystal-induced 
arthritis and metallosis may return false-positive 
results, but its diagnostic accuracy does not increase 
 J. Bone Joint Infect. 2019, Vol. 4 
 
http://www.jbji.net 
172 
when providing a higher cut-off value.  
For a single patient, it is important to take these 
variables into account, and, from a clinical point of 
view, PJI should be suspected when the cell count 
result falls above a “range” of cell count values 
instead of a precise cut-off value.  
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